Cargando…

Predicting Sustained Clinical Response to Rituximab in Moderate to Severe Systemic Manifestations of Primary Sjögren Syndrome

OBJECTIVE: To assess outcomes of repeat rituximab cycles and identify predictors of sustained clinical response in systemic manifestations of primary Sjögren syndrome (pSS). METHODS: An observational study was conducted in 40 rituximab‐treated patients with pSS. Clinical response was defined as a 3‐...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pepple, Sophanit, Arnold, Jack, Vital, Edward M., Rawstron, Andrew C., Pease, Colin T., Dass, Shouvik, Emery, Paul, Md Yusof, Md Yuzaiful
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wiley Periodicals, Inc. 2022
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9374056/ https://www.ncbi.nlm.nih.gov/pubmed/35666029 http://dx.doi.org/10.1002/acr2.11466

Ejemplares similares

A Personalized Rituximab Retreatment Approach Based on Clinical and B-Cell Biomarkers in ANCA-Associated Vasculitis
por: Arnold, Jack, et al.
Publicado: (2022)

Breakthrough SARS-CoV-2 infections and prediction of moderate-to-severe outcomes during rituximab therapy in patients with rheumatic and musculoskeletal diseases in the UK: a single-centre cohort study
por: Md Yusof, Md Yuzaiful, et al.
Publicado: (2023)

Biologic Sequencing in Systemic Lupus Erythematosus: After Secondary Non-response to Rituximab, Switching to Humanised Anti-CD20 Agent Is More Effective Than Belimumab
por: Hassan, Sabih Ul, et al.
Publicado: (2020)

Predicting and managing primary and secondary non-response to rituximab using B-cell biomarkers in systemic lupus erythematosus
por: Md Yusof, Md Yuzaiful, et al.
Publicado: (2017)

Early intervention in systemic lupus erythematosus: time for action to improve outcomes and health-care utilization
por: Md Yusof, Md Yuzaiful, et al.
Publicado: (2021)

Comprehensive genetic and functional analyses of Fc gamma receptors influence on response to rituximab therapy for autoimmunity
por: Robinson, James I., et al.
Publicado: (2022)

Functionally impaired plasmacytoid dendritic cells and non-haematopoietic sources of type I interferon characterize human autoimmunity
por: Psarras, Antonios, et al.
Publicado: (2020)

Responsiveness of clinical and ultrasound outcome measures in musculoskeletal systemic lupus erythematosus
por: Mahmoud, Khaled, et al.
Publicado: (2019)

Editorial: Advance in B-cell therapies for the treatment of rheumatic and musculoskeletal diseases
por: Md Yusof, Md Yuzaiful, et al.
Publicado: (2022)

Rituximab Therapy for Primary Sjögren’s Syndrome
por: Chen, Yi Han, et al.
Publicado: (2021)

Prediction of autoimmune connective tissue disease in an at-risk cohort: prognostic value of a novel two-score system for interferon status
por: Md Yusof, Md Yuzaiful, et al.
Publicado: (2018)

Plucked hair follicles from patients with chronic discoid lupus erythematosus show a disease-specific molecular signature
por: Shalbaf, Mohammad, et al.
Publicado: (2019)

Controversies on Rituximab Therapy in Sjögren Syndrome-Associated Lymphoproliferation
por: Quartuccio, Luca, et al.
Publicado: (2009)

Severe Headache in Primary Sjögren’s Syndrome Responded to Rituximab
por: Kudsi, Maysoun, et al.
Publicado: (2023)

Opportunities arising from the COVID-19: an international orthopaedic surgeons’ perspective
por: Howard, Anthony, et al.
Publicado: (2022)

Effect of rituximab on a salivary gland ultrasound score in primary Sjögren’s syndrome: results of the TRACTISS randomised double-blind multicentre substudy
por: Fisher, Benjamin A, et al.
Publicado: (2018)

B Cell Tetherin: A Flow Cytometric Cell‐Specific Assay for Response to Type I Interferon Predicts Clinical Features and Flares in Systemic Lupus Erythematosus
por: El‐Sherbiny, Yasser M., et al.
Publicado: (2020)

Laryngological manifestations of Sjögren’s syndrome
por: Kamiński, Bartłomiej
Publicado: (2019)

Pulmonary manifestations of Sjögren's syndrome
por: Flament, Thomas, et al.
Publicado: (2016)

Ultrasound to identify systemic lupus erythematosus patients with musculoskeletal symptoms who respond best to therapy: the US Evaluation For mUsculoskeletal Lupus longitudinal multicentre study
por: Mahmoud, Khaled, et al.
Publicado: (2021)

Severe headache in primary Sjögren’s syndrome treated with intrathecal rituximab
por: Tjensvoll, Anne Bolette, et al.
Publicado: (2019)

Neurological manifestations of primary Sjögren’s syndrome
por: Perzyńska-Mazan, Joanna, et al.
Publicado: (2018)

Ophthalmologic Manifestations of Primary Sjögren’s Syndrome
por: Roszkowska, Anna Maria, et al.
Publicado: (2021)

Catatonia and Psychosis as Manifestations of Primary Sjögren’s Syndrome
por: Rosado, Steeve Neves, et al.
Publicado: (2018)

Lymphoma's manifestations in Sjögren's syndrome: is there a relation?
por: Limares, Fabrícia Dias Colombano, et al.
Publicado: (2015)

The Spectrum of Extraglandular Manifestations in Primary Sjögren’s Syndrome
por: Mihai, Ancuta, et al.
Publicado: (2023)

Rituximab for Sjögren syndrome–associated type II mixed cryoglobulinemic cerebral vasculitis
por: Lioger, Bertrand, et al.
Publicado: (2016)

Self-risk assessment for patients with rheumatic disease during the COVID-19 pandemic
por: Marzo-Ortega, Helena, et al.
Publicado: (2020)

Persistence and selection of an expanded B-cell clone in the setting of rituximab therapy for Sjögren’s syndrome
por: Hershberg, Uri, et al.
Publicado: (2014)

Thrombotic Thrombocytopenic Purpura Treated with Rituximab Associated with Primary Sjögren's Syndrome and Primary Hypothyroidism
por: Okumura, Taiki, et al.
Publicado: (2019)

A randomized, phase II study of sequential belimumab and rituximab in primary Sjögren’s syndrome
por: Mariette, Xavier, et al.
Publicado: (2022)

Nodular Pulmonary Amyloidosis: A Manifestation of Sjögren's Syndrome
por: Gómez Correa, Gustavo Adolfo, et al.
Publicado: (2018)

Athetoid Movements as Initial Manifestation of Primary Sjögren Syndrome
por: Alvarado‐Franco, Norma L., et al.
Publicado: (2018)

Musculoskeletal Manifestations in Sjogren’s Syndrome: An Orthopedic Point of View
por: Rozis, Meletios, et al.
Publicado: (2021)

Cardiac Manifestations of Sjogren's Syndrome: A Review of Literature
por: Farrukh, Larabe, et al.
Publicado: (2023)

Cardiovascular Risk Factors in Women With Primary Sjögren's Syndrome: United Kingdom Primary Sjögren's Syndrome Registry Results
por: Juarez, M, et al.
Publicado: (2014)

Beyond the Glands: An in-Depth Perspective of Neurological Manifestations in Sjögren’s Syndrome
por: Voigt, Alexandria, et al.
Publicado: (2014)

Orofacial Manifestations and Temporomandibular Disorders of Sjögren Syndrome: An Observational Study
por: Crincoli, Vito, et al.
Publicado: (2018)

Lipschütz Genital Ulceration as Initial Manifestation of Primary Sjögren's Syndrome
por: de Castro Coelho, Filipa, et al.
Publicado: (2018)

Limbic Encephalitis as a Heralding Manifestation of Primary Sjogren’s Syndrome
por: Verma, Rajesh, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ppumbv4q67kqf86id8k747akgb